Vitti Long Haul

Vitti Long Haul works to advance new therapies for people facing long lasting effects of COVID 19, especially pulmonary fibrosis and long haul symptoms. Our treatments VL PX10 and VL P22 are created from mesenchymal stem cells, exosomes, and biomaterials and are in Phase 2 clinical trials. For patients who do not qualify for trials, we offer access through a physician led Expanded Access Program. Guided by FDA standards and strong scientific research, Vitti Long Haul is committed to safe and innovative care. Patients and physicians can contact us to learn more.